Literature DB >> 17139442

Anaemia-related impairment in quality of life in elderly cancer patients prior to chemotherapy.

Ulrich Wedding1, Bernd Röhrig, Ludger Pientka, Klaus Höffken.   

Abstract

PURPOSE: Quality of life (QoL) of patients with cancer is a major area of concern for both patients and their physicians. PATIENTS AND METHODS: We investigated QoL with the EORTC-QLQ-C30 questionnaire with reference to anaemia and Karnofsky Performance Status (KPS) prior to the start of chemotherapy in 477 patients: 195 elderly cancer patients (Group A), 152 younger cancer patients (Group B), and 130 patients aged 60 years or older admitted for non-cancer related disorders (Group C).
RESULTS: In univariate analysis QoL was significantly worse in 8 out of 15 scales in anaemic compared to non anaemic patients in Group A, in 2 in Group B, and in 7 in Group C. In ANOVA analysis including KPS and haemoglobin status, the influence of anaemia and KPS independently persists in most scales in Group A, in some in Group C, but not in Group B.
CONCLUSIONS: Anaemia and functional impairment are independently related to QoL in elderly cancer and elderly medical patients, but not in younger cancer patients.

Entities:  

Mesh:

Year:  2006        PMID: 17139442     DOI: 10.1007/s00432-006-0167-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

1.  Performance status assessment in cancer patients.

Authors:  C Conill; E Verger; M Salamero
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

2.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

3.  Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system.

Authors:  S B Yellen; D F Cella; K Webster; C Blendowski; E Kaplan
Journal:  J Pain Symptom Manage       Date:  1997-02       Impact factor: 3.612

4.  Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+ 3).

Authors:  M J Hjermstad; P M Fayers; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

5.  The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.

Authors:  V Mor; L Laliberte; J N Morris; M Wiemann
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

Review 6.  Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy.

Authors:  Simon Jean-Pierre Van Belle; Véronique Cocquyt
Journal:  Crit Rev Oncol Hematol       Date:  2003-07       Impact factor: 6.312

7.  Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?

Authors:  Paulo H M Chaves; Bimal Ashar; Jack M Guralnik; Linda P Fried
Journal:  J Am Geriatr Soc       Date:  2002-07       Impact factor: 5.562

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 9.  The challenges and achievements involved in implementing Quality of Life research in cancer clinical trials.

Authors:  A Bottomley; V Vanvoorden; H Flechtner; P Therasse
Journal:  Eur J Cancer       Date:  2003-02       Impact factor: 9.162

10.  The Karnofsky Performance Status Scale re-examined: a cross-validation with the EORTC-C30.

Authors:  J Schaafsma; D Osoba
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.